Alkem Laboratories Ltd approves Q2FY27 results with revenue of ₹4,552 crore, up 13.8% YoY
- Consolidated EBITDA was ₹1,025 crore, up 11.3% YoY; EBITDA margin was 22.5%.
- Net profit after non-controlling interest was ₹675 crore, down 11.7% YoY.
- Results included a ₹35 crore exceptional recovery; Occlutech was consolidated after Alkem acquired a 55% stake.
- Auditors issued unmodified limited-review conclusions.
